Edition:
United States

Navidea Biopharmaceuticals Inc (NAVB.A)

NAVB.A on American Stock Exchange

0.39USD
3:36pm EDT
Change (% chg)

$-0.01 (-1.71%)
Prev Close
$0.40
Open
$0.42
Day's High
$0.42
Day's Low
$0.39
Volume
13,288
Avg. Vol
30,696
52-wk High
$1.14
52-wk Low
$0.29

Chart for

About

Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The Company is developing multiple precision-targeted products based on the Manocept platform to help identify the sites and pathways of undetected disease.... (more)
No analyst recommendations are available for .

Overall

Beta: -0.64
Market Cap(Mil.): $64.36
Shares Outstanding(Mil.): 162.21
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 80.15 16.18
EPS (TTM): -- -- --
ROI: -- 3.01 14.60
ROE: -- 4.76 13.87

BRIEF-Navidea Biopharmaceuticals reports Q2 loss per share $0.03

* Navidea Biopharmaceuticals reports second quarter 2017 financial results

Aug 08 2017

BRIEF-Navidea says on June 26, co and FTI Consulting entered into settlement agreement

* Navidea biopharmaceuticals inc - on june 26, co and fti consulting entered into a settlement agreement - sec filing

Jun 29 2017

BRIEF-Navidea enters exclusive license, distribution agreement for India with Sayre Therapeutics

* Navidea enters exclusive license and distribution agreement for India with Sayre Therapeutics

Jun 20 2017

BRIEF-Navidea says commercial partner Norgine launches lymphoseek in Europe

* Navidea’s commercial partner, Norgine B.V., launches lymphoseek in Europe

Jun 12 2017

BRIEF-Navidea Biopharmaceuticals reports Q1 earnings $0.53/shr

* Navidea Biopharmaceuticals reports first quarter 2017 financial results

May 09 2017

BRIEF-Navidea Q4 loss per share $0.02

* Navidea provides corporate update and reports full year 2016 results

Mar 29 2017

Competitors

  Price Chg
General Electric Company (GE.N) $24.10 -0.35
Bayer AG (BAYGn.DE) €109.90 -0.60
Bayer AG (BAYE.F) -- --
Eli Lilly and Co (LLY.N) $81.62 -0.90

Earnings vs. Estimates